SCHEMBL344646

SCHEMBL344646

COc1cccc(C(=O)C(=O)O)c1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
ALDH1A1 P00352 5/20 0.51
TP53 P04637 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 1/20 0.51
KMT2A Q03164 3/20 0.50
POLB P06746 3/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
MEN1 O00255 1/20 0.50
GAA P10253 4/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 2/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29603325 0.85 MAPT (0.59) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL152563 0.85 MAPT (0.59) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL870485 0.84 NPC1 (0.52) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL18663736 0.84 RAB9A (0.54) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL28776139 0.83 MAPT (0.58) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL14333373 0.83 ALDH1A1 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL7469868 0.83 MAPT (0.58) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL27617245 0.83 MAPT (0.58) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL9191986 0.83 MAPT (0.58) NPC1RAB9AALDH1A1TP53SMN1; SMN2
Hydrochloric Acid SCHEMBL4229730 0.83 MAPT (0.58) NPC1RAB9AALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080427-A1 METHOD FOR PRODUCING UV-ABSORBING HYBRID MATERIALS BASF SE (DE) 2009-07-02 WO claimed
US-20040102446-A1 Tricyclic quinoxaline derivatives as a uv filter MERCK PATENT GMBH (DE) 2004-05-27 US claimed
EP-3663366-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2025-01-08 EP disclosed
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 EP disclosed
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients BASF SE (DE) 2022-09-06 US disclosed
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof BASF SE (DE) 2021-06-29 US disclosed
EP-2758041-B1 LOW-MOLECULAR MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 AND USE OF SAME BASF SE (DE) 2021-01-13 EP disclosed
EP-3675809-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-07-08 EP disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 US disclosed
EP-2501761-B1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2020-06-17 EP disclosed
EP-3663366-A2 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS Symrise AG (DE) 2020-06-10 EP disclosed
EP-0945125-A1 Cosmetic and pharmaceutical compositions containing photostable uv filters BASF AKTIENGESELLSCHAFT (DE) 1999-09-29 EP disclosed
CN-1224032-A Use of isoindolinone derivatives as stabilizers for organic materials BASF AG (DE) 1999-07-28 CN disclosed
EP-0924246-A1 Uses of Isoindolinone derivatives BASF AKTIENGESELLSCHAFT (DE) 1999-06-23 EP disclosed
CN-1218806-A Sorbic acid vitamin C ester BASF AG (DE) 1999-06-09 CN disclosed
EP-0917871-A2 Cosmetic and pharmaceutical compositions comprising ascorbic acid derivatives BASF AKTIENGESELLSCHAFT (DE) 1999-05-26 EP disclosed
EP-0916662-A2 Ascorbylsorbate BASF AKTIENGESELLSCHAFT (DE) 1999-05-19 EP disclosed
EP-0911020-A1 Methylstyrene derivatives as UV-filters and cosmetic and pharmaceutical preparations containing them BASF AKTIENGESELLSCHAFT (DE) 1999-04-28 EP disclosed
EP-0852137-A2 Cosmetic compositions containing a photostable UV-A filter BASF AKTIENGESELLSCHAFT (DE) 1998-07-08 EP disclosed
EP-0826361-A1 Cosmetical preparations containing photostable UV-A filters BASF AKTIENGESELLSCHAFT (DE) 1998-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients TRPM8, TRPM7, TRPM5 NPC1 708/4885RAB9A 3290/4885ALDH1A1 1810/4885
US-20040102446-A1 Tricyclic quinoxaline derivatives as a uv filter CUTA, CYP1B1, TPH1 NPC1 3313/4885RAB9A 1776/4885ALDH1A1 289/4885
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof TRPM8, TRPM7, TRPM2 NPC1 2315/4885RAB9A 2487/4885ALDH1A1 3977/4885
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM5 NPC1 708/4885RAB9A 3290/4885ALDH1A1 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.